WISP3, the gene responsible for the human skeletal disease progressive pseudorheumatoid dysplasia, is not essential for skeletal function in mice

被引:56
作者
Kutz, WE
Gong, YQ
Warman, ML
机构
[1] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA
[3] Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH USA
关键词
D O I
10.1128/MCB.25.1.414-421.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In humans, loss-of-function mutations in WISP3 cause the autosomal recessive skeletal disease progressive pseudorheumatoid dysplasia (PPD) (Online Mendelian Inheritance in Man database number 208230). WISP3 encodes Wnt1-inducible signaling protein 3, a cysteine-rich, multidomain, secreted protein, whose paralogous CCN (connective tissue growth factor/cysteine-rich protein 61/nephroblastoma overexpressed) family members have been implicated in diverse biologic processes including skeletal, vascular, and neural development. To understand the role of WISP3 in the skeleton, we targeted the Wisp3 gene in mice by creating a mutant allele comparable to that which causes human disease. We also created transgenic mice that overexpress human WISP3 in cartilage. Surprisingly, homozygous Wisp3 mutant mice appear normal and do not recapitulate any of the morphological, radiographic, or histological abnormalities seen in patients with PPD. Mice that overexpress WISP3 are also normal. We conclude, that in contrast to humans, Wisp3 is not an essential participant during skeletal growth or homeostasis in mice.
引用
收藏
页码:414 / 421
页数:8
相关论文
共 28 条
[1]   The connective tissue growth factor cysteine-rich 61 nephroblastoma overexpressed (CCN) family [J].
Brigstock, DR .
ENDOCRINE REVIEWS, 1999, 20 (02) :189-206
[2]  
DEWIRE P, 2001, OSTEOARTHRITIS DIAGN, P49
[3]   In vivo morphometry and functional analysis of human articular cartilage with quantitative magnetic resonance imaging - from image to data, from data to theory [J].
Eckstein, F ;
Reiser, M ;
Englmeier, KH ;
Putz, R .
ANATOMY AND EMBRYOLOGY, 2001, 203 (03) :147-173
[4]   Clinical, radiographic, and genetic diagnosis of progressive pseudorheumatoid dysplasia in a patient with severe polyarthropathy [J].
Ehl, S ;
Uhl, M ;
Berner, R ;
Bonafé, L ;
Superti-Furga, A ;
Kirchhoff, A .
RHEUMATOLOGY INTERNATIONAL, 2004, 24 (01) :53-56
[5]   Progressive pseudorheumatoid dysplasia: Report of a family and review [J].
ElShanti, HE ;
Omari, HZ ;
Qubain, HI .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (07) :559-563
[6]   VASCULAR EVENTS ASSOCIATED WITH THE APPEARANCE OF THE SECONDARY CENTER OF OSSIFICATION IN THE MURINE DISTAL FEMORAL EPIPHYSIS [J].
FLOYD, WE ;
ZALESKE, DJ ;
SCHILLER, AL ;
TRAHAN, C ;
MANKIN, HJ .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1987, 69A (02) :185-190
[7]   IDENTIFICATION OF A PHENOTYPE-SPECIFIC ENHANCER IN THE 1ST INTRON OF THE RAT COLLAGEN-II GENE [J].
HORTON, W ;
MIYASHITA, T ;
KOHNO, K ;
HASSELL, JR ;
YAMADA, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) :8864-8868
[8]   Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia [J].
Hurvitz, JR ;
Suwairi, WM ;
Van Hul, W ;
El-Shanti, H ;
Superti-Furga, A ;
Roudier, J ;
Holderbaum, D ;
Pauli, RM ;
Herd, JK ;
Van Hul, E ;
Rezai-Delui, H ;
Legius, E ;
Le Merrer, M ;
Al-Alami, J ;
Bahabri, SA ;
Warman, ML .
NATURE GENETICS, 1999, 23 (01) :94-98
[9]   Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development [J].
Ivkovic, S ;
Yoon, BS ;
Popoff, SN ;
Safadi, FF ;
Libuda, DE ;
Stephenson, RC ;
Daluiski, A ;
Lyons, KM .
DEVELOPMENT, 2003, 130 (12) :2779-2791
[10]   WISP3 is a novel tumor suppressor gene of inflammatory breast cancer [J].
Kleer, CG ;
Zhang, YH ;
Pan, Q ;
van Golen, KL ;
Wu, ZF ;
Livant, D ;
Merajver, SD .
ONCOGENE, 2002, 21 (20) :3172-3180